Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P G Tarassoff

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
The Journal of Clinical Investigation|May 1, 1983
Pyridoxal phosphate as an antisickling agent in vitroJ A Kark, P G Tarassoff, R Bongiovanni
Cancer|January 1, 1994
Phase II trial of gemcitabine in patients with advanced gastric cancerK Christman, D Kelsen, L Saltz, et al.
American Journal of Hematology|January 1, 1986
Successful renal transplantation for Epstein syndromeB M Alving, P G Tarassoff, J Moore, et al.
The Journal of Clinical Investigation|October 1, 1978
Inhibition of erythrocyte sickling in vitro by pyridoxalJ A Kark, M P Kale, P G Tarassoff, et al.
Blood Cells|January 1, 1982
Modification of intracellular hemoglobin with pyridoxal and pyridoxal 5'-phosphateJ A Kark, R Bongiovanni, C U Hicks, et al.
Investigational New Drugs|January 1, 1994
Phase II trial of gemcitabine (2,2'-difluorodeoxycytidine) in patients with adenocarcinoma of the pancreasE S Casper, M R Green, D P Kelsen, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 1, 1996
A phase II trial of gemcitabine in patients with 5-FU-refractory pancreas cancerM L Rothenberg, M J Moore, M C Cripps, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
The Journal of Clinical Investigation|May 1, 1983
Pyridoxal phosphate as an antisickling agent in vitroJ A Kark, P G Tarassoff, R Bongiovanni
Cancer|January 1, 1994
Phase II trial of gemcitabine in patients with advanced gastric cancerK Christman, D Kelsen, L Saltz, et al.
American Journal of Hematology|January 1, 1986
Successful renal transplantation for Epstein syndromeB M Alving, P G Tarassoff, J Moore, et al.
The Journal of Clinical Investigation|October 1, 1978
Inhibition of erythrocyte sickling in vitro by pyridoxalJ A Kark, M P Kale, P G Tarassoff, et al.
Blood Cells|January 1, 1982
Modification of intracellular hemoglobin with pyridoxal and pyridoxal 5'-phosphateJ A Kark, R Bongiovanni, C U Hicks, et al.
Investigational New Drugs|January 1, 1994
Phase II trial of gemcitabine (2,2'-difluorodeoxycytidine) in patients with adenocarcinoma of the pancreasE S Casper, M R Green, D P Kelsen, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 1, 1996
A phase II trial of gemcitabine in patients with 5-FU-refractory pancreas cancerM L Rothenberg, M J Moore, M C Cripps, et al.
Pageof 1